Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing innovative therapies for patients living with rare neurological disorders as well as patients living with other neurological dise…
Analysis
Hidden champion
Harmony Biosciences Holdings, Inc. is what we call a hidden champion: a strong business that the market is not pricing as one.
The price is attractive. You pay 11.9× its owner earnings: the cash an owner could take out each year, which is in the historically attractive zone. At today's price, the market is assuming roughly -1% yearly growth; analysts expect 21%. The price, in other words, assumes less than the experts do.
The trajectory is moderate and the balance sheet is sturdy. The company scores 14/20 on our value-creation score: strong value creator. Analyst sentiment is cautious.
Nothing is flagged here: no red or amber gates, no divergence between profits and cash. That is itself information: the numbers are straightforward. As always: this describes the company's numbers; it is not a recommendation.
360° rank · history
1007550250
Jan 202382
88
2023202420252026
All-time high
98
Jan 2025
All-time low
34
Jan 2024
Average rank
74
across all years
Detailed & Historical Ranks
Deep dive into 15 detailed ranks and 3 years of history.
Current202520242023
Price/Sales
84
41
31
28
Price/Earnings
36
67
85
64
Price/Book
65
31
18
4
Dividend Yield
1
1
1
1
Value (overall)
72
32
34
17
Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.